Distributed by

Marketed by

Distributed by

Marketed by

AMGEN (THAILAND) LIMITED

Featured products of Amgen

Amgevita

Amgevita soln for inj 20 mg/0.4 mL

adalimumab

Packing/Price

1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.

Amgevita soln for inj 40 mg/0.8 mL

adalimumab

Packing/Price

1's ((auto-injector)) 1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.

Blincyto

Blincyto powd for soln for infusion 35 mcg

blinatumomab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX07 - blinatumomab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Evenity

Evenity soln for inj 105 mg/1.17 mL

romosozumab

Packing/Price

2 × 1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX06 - romosozumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Kyprolis

Kyprolis inj 30 mg

carfilzomib

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XG02 - carfilzomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.

Lumakras

Lumakras FC tab 120 mg

sotorasib

Packing/Price

7 × 8's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XX73 - sotorasib : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.

Mvasi

Mvasi conc for soln for infusion 100 mg/4 mL

bevacizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

Neulastim

Neulastim pre-filled inj 6 mg/0.6 mL

pegfilgrastim

Packing/Price

(type I glass) 0.6 mL x 1's

MIMS Class

Supportive Care Therapy, Haematopoietic Agents

ATC Classification

L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Neupogen

Neupogen pre-filled inj 30 Million unit/0.5 mL

filgrastim

Packing/Price

1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Parsabiv

Parsabiv soln for inj 2.5 mg/0.5 mL

etelcalcetide

Packing/Price

10 × 1's

MIMS Class

Other Agents Affecting Metabolism

ATC Classification

H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.

Prolia

Prolia soln for inj 60 mg/mL

denosumab

Packing/Price

1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Repatha

Repatha soln for inj 140 mg/mL

evolocumab

Packing/Price

(autoinjector) 1's

MIMS Class

Dyslipidaemic Agents

ATC Classification

C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.

Vectibix

Vectibix conc for soln for infusion 100 mg/5 mL

panitumumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.

Xgeva

Xgeva soln for inj 120 mg/1.7 mL (70 mg/mL)

denosumab

Packing/Price

1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Distributed by Zuellig Pharma

Amgevita

Amgevita soln for inj 20 mg/0.4 mL

adalimumab

Packing/Price

1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.

Amgevita soln for inj 40 mg/0.8 mL

adalimumab

Packing/Price

1's ((auto-injector)) 1's

MIMS Class

Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

ATC Classification

L04AB04 - adalimumab : Belongs to the class of tumor necrosis factor alpha (TNF-alpha) inhibitors. Used as immunosuppressants.

Blincyto

Blincyto powd for soln for infusion 35 mcg

blinatumomab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FX07 - blinatumomab : Belongs to the class of other monoclonal antibodies and antibody drug conjugates. Used in the treatment of cancer.

Evenity

Evenity soln for inj 105 mg/1.17 mL

romosozumab

Packing/Price

2 × 1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX06 - romosozumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Kyprolis

Kyprolis inj 30 mg

carfilzomib

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XG02 - carfilzomib : Belongs to the class of proteasome inhibitors. Used in the treatment of cancer.

Lumakras

Lumakras FC tab 120 mg

sotorasib

Packing/Price

7 × 8's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01XX73 - sotorasib : Belongs to the class of other antineoplastic agents. Used in the treatment of cancer.

Mvasi

Mvasi conc for soln for infusion 100 mg/4 mL

bevacizumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FG01 - bevacizumab : Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.

Neulastim

Neulastim pre-filled inj 6 mg/0.6 mL

pegfilgrastim

Packing/Price

(type I glass) 0.6 mL x 1's

MIMS Class

Supportive Care Therapy, Haematopoietic Agents

ATC Classification

L03AA13 - pegfilgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Neupogen

Neupogen pre-filled inj 30 Million unit/0.5 mL

filgrastim

Packing/Price

1's

MIMS Class

Haematopoietic Agents, Supportive Care Therapy

ATC Classification

L03AA02 - filgrastim : Belongs to the class of colony stimulating factors. Used as immunostimulants.

Parsabiv

Parsabiv soln for inj 2.5 mg/0.5 mL

etelcalcetide

Packing/Price

10 × 1's

MIMS Class

Other Agents Affecting Metabolism

ATC Classification

H05BX04 - etelcalcetide : Belongs to the class of other anti-parathyroid agents. Used in the management of calcium homeostasis.

Prolia

Prolia soln for inj 60 mg/mL

denosumab

Packing/Price

1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Repatha

Repatha soln for inj 140 mg/mL

evolocumab

Packing/Price

(autoinjector) 1's

MIMS Class

Dyslipidaemic Agents

ATC Classification

C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.

Vectibix

Vectibix conc for soln for infusion 100 mg/5 mL

panitumumab

Packing/Price

1's

MIMS Class

Targeted Cancer Therapy

ATC Classification

L01FE02 - panitumumab : Belongs to the class of EGFR (Epidermal Growth Factor Receptor) inhibitors. Used in the treatment of cancer.

Xgeva

Xgeva soln for inj 120 mg/1.7 mL (70 mg/mL)

denosumab

Packing/Price

1's

MIMS Class

Agents Affecting Bone Metabolism

ATC Classification

M05BX04 - denosumab : Belongs to the class of other drugs affecting bone structure and mineralization. Used in the treatment of bone diseases.

Marketed by Zuellig Pharma

Repatha

Repatha soln for inj 140 mg/mL

evolocumab

Packing/Price

(autoinjector) 1's

MIMS Class

Dyslipidaemic Agents

ATC Classification

C10AX13 - evolocumab : Belongs to the class of other lipid modifying agents.